Literature DB >> 1716179

Intravascular stents in the management of superior vena cava syndrome.

N Solomon1, M H Wholey, C R Jarmolowski.   

Abstract

Superior vena cava syndrome can be effectively palliated with the use of intravascular stents. Adjunctive modalities which may be utilized prior to stent placement are thrombolytic therapy and balloon angioplasty. Six patients with an underlying malignancy were treated with these modalities. Complete resolution of symptoms occurred in five patients, and partial resolution occurred in the sixth. Two of the patients who had initial, complete resolution of symptoms had recurrences. One involved rethrombosis of the superior vena cava which occurred twice and required percutaneous thrombectomy, and the second involved restenosis requiring a percutaneous transluminal angioplasty of the SVC just distal to the stent. Both of these patients with second procedures, again, had complete resolution of symptoms. Intravascular stents are a valuable additional treatment of superior vena cava syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716179     DOI: 10.1002/ccd.1810230404

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  6 in total

1.  Stent-graft in the management of superior vena cava syndrome.

Authors:  D H Chin; B D Petersen; H Timmermans; J Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jul-Aug       Impact factor: 2.740

2.  Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome.

Authors:  S Sasano; T Onuki; M Mae; K Oyama; M Sakuraba; S Nitta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-03

3.  Venous recanalization by metallic stents after failure of balloon angioplasty or surgery: four-year experience.

Authors:  G K Nazarian; W R Austin; S A Wegryn; H Bjarnason; D J Stackhouse; W R Castañeda-Zúñiga; D W Hunter
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jul-Aug       Impact factor: 2.740

4.  Stenting and superior vena caval syndrome.

Authors:  P Wilkinson; J MacMahon; L Johnston
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

5.  Expandable Wallstent for the treatment of obstruction of the superior vena cava.

Authors:  A F Watkinson; D M Hansell
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

Review 6.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.